Business News

Medacta Group price target lowered to CHF 107 from CHF 109 at Morgan Stanley

Provention Bio price target raised to $30 from $24 at Chardan


Medacta Group price target lowered to CHF 107 from CHF 109 at Morgan Stanley

Click Here to Read the Full Original Article at TipRanks Financial Blog…